DS
IMGN

David Shaw’s Immunogen Inc IMGN Stock Holding History

David Shaw’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,700
Closed -$175K – 4602
2014
Q1 		$175K Hold
11,700
– – ﹤0.01% 4103
2013
Q4 		$172K Buy
+11,700
New +$180K ﹤0.01% 4299

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

David Shaw's IMGN Position: Q1 2024 in Review

David Shaw sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,522,797 shares — an estimated $134M sold.

David Shaw first reported a position in IMGN in Q4 2014 and held it in 31 quarters. The position peaked at $134M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • David Shaw reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 4,522,797 Immunogen Inc shares in Q1 2024, an estimated $134M.
  • David Shaw first reported a position in Immunogen Inc in Q4 2014 and held it in 31 quarters.
  • David Shaw's Immunogen Inc position peaked at $134M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.